George Rieveschl, Inventor of Benadryl, Dies
CINCINNATIUniversity of Cincinnati (UC) alumnus and engineering professor emeritus George Rieveschl, PhD, known for inventing Benadryl, the worlds first effective antihistamine, died today at Christ Hospital, Cincinnati. He was 91.
A long-time supporter of the College of Medicine and the university as a whole, Dr. Rieveschl developed the widely used treatment for allergy 61 years ago.
Dr. Rieveschl was also the founding chairman of the University Foundation Board of Trustees.
Rieveschl was a chemistry professor at UC when he invented Benadryl.
He found to this surprise that a two-part compound he was originally testing to improve muscle-relaxing medications dramatically blocked histamine, the naturally released chemical that narrows air passages in the lungs and causes inflammation.
This breakthrough led, in 1946, to Benadryls becoming the first FDA-approved prescription antihistamine. First produced by Parke, Davis and Company, the drug is now distributed over-the-counter by the Parke-Davis division of Pfizer.
A 1937 alumnus of UC, Dr. Rieveschl spent 26 years working in the chemical industry as both a scientist and a consultant before returning to UC in 1970.
He is survived by his wife, Ellen, and two sons.
Related Stories
Can new rules in Ohio address a pharmacy staffing shortage and...
May 17, 2024
The University of Cincinnati's Michael Hegener joined WVXU's Cincinnati Edition to discuss recent rules released by the Ohio Board of Pharmacy designed to address pharmacy staffing.
Is ketamine the answer to treatment-resistant depression?
May 16, 2024
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition to discuss the use of ketamine and esketamine to treat treatment-resistant depression.
UC study: Severe ischemic strokes rare in total patient...
May 15, 2024
The University of Cincinnati’s Yasmin Aziz will present research at the European Stroke Organisation Conference that found severe ischemic strokes with the most severe damage are rare in the total stroke patient population.